3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Non-Hodgkin
3
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Triple Negative Breast Neoplasms
1
Neuroblastoma
1
Multiple Myeloma
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Hematologic Diseases
1
Glioblastoma
1
Ganglioneuroblastoma
1
Burkitt Lymphoma
1
Astrocytoma
1
Interventions
X-Rays
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Magnetic Resonance Spectroscopy
4
Vincristine
3
Temozolomide
3
Specimen Handling
3
Irinotecan
3
Cyclophosphamide
3
Biopsy
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
ensartinib
2
Radiotherapy
2
temsirolimus
1
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
erdafitinib
1
cabozantinib
1
atezolizumab
1
Vinorelbine
1
Vemurafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdomyosarcoma
×
Leukapheresis
×
30 days
×
Clear all
No trials found.